Althea Acquires Altus’ Technologies

5/3/10Follow @bvbigelow

San Diego CRO Althea Technologies says it is acquiring the assets and IP portfolio of Altus Pharmaceuticals, a Waltham, MA, biotech that filed for bankruptcy liquidation seven months ago. Financial terms were not disclosed. Altus had been developing an injectable human growth hormone to treat diseases.  Althea said applications of Altus’ technology range from therapeutics to protein purification and catalysis.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @bvbigelow

By posting a comment, you agree to our terms and conditions.